S. Davidson

发表

A comparison of tracer kinetic models for T1‐weighted dynamic contrast‐enhanced MRI: Application in carcinoma of the cervix

S. Sourbron, D. Buckley, Andrew P Jones, 2010, Magnetic resonance in medicine.

A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy

J Chang-Claude, N G Burnet, J. Chang-Claude, 2012, British Journal of Cancer.

The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales.

R. Swindell, S. Davidson, M. Burns, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Measurement tools for gastrointestinal symptoms in radiation oncology

C. West, S. Davidson, 2009, Current opinion in supportive and palliative care.

Salvaging locoregional recurrence with radiotherapy after surgery in early cervical cancer.

J. Livsey, R. Swindell, S. Davidson, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Pattern of failure and long-term morbidity in patients undergoing postoperative radiotherapy for cervical cancer

H. Kitchener, J. Livsey, R. Swindell, 2006, International Journal of Gynecologic Cancer.

Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary.

C. West, S. Bentzen, R. Swindell, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Scoring of treatment-related late effects in prostate cancer.

R. Cowan, J. Logue, J. Livsey, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity.

J. Hendry, S. Roberts, C. West, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

David L Buckley, J. R. Sykes, Catharine M L West, 2002, International journal of radiation oncology, biology, physics.

The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability

L. Kershaw, C. West, C. Rose, 2017, British Journal of Cancer.

The intrinsic radiosensitivity of normal and tumour cells.

J H Hendry, J. Hendry, S. Roberts, 1998, International journal of radiation biology.

Expression of Ku70 correlates with survival in carcinoma of the cervix

G. Margison, C. West, S. Davidson, 2000, British Journal of Cancer.

Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix.

C. West, S. Davidson, J. Dickson, 2000, International journal of radiation oncology, biology, physics.

The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data.

C. West, S. Davidson, R. Hunter, 1995, International journal of radiation oncology, biology, physics.

Screening for Cancer-Related Neuropathic Pain in the Oncology Outpatient Setting in the United Kingdom

S. Davidson, A. Birtle, G. Atkinson, 2013 .

Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers.

J. Hendry, G. Margison, C. West, 1998, British Journal of Cancer.

Evaluation of multiple biologic parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors

P. Stern, C. West, P. Stern, 1992, International Journal of Gynecologic Cancer.

Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix.

C. West, S. Davidson, R. Hunter, 1989, International journal of radiation biology.

Changes in oxygenation during radiotherapy in carcinoma of the cervix.

S. Roberts, J. Logue, C. West, 1999, International Journal of Radiation Oncology, Biology, Physics.

Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy

J. Mclaughlin, J. Limdi, Y. Ang, 2013, Supportive Care in Cancer.

Prognostic significance of c-erb B-2 protein expression in carcinoma of the cervix treated with radiotherapy

J. Hendry, C. West, T. Nishioka, 1999, Journal of Cancer Research and Clinical Oncology.

SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.

S. Chan, N. Reed, J. Paul, 2011, Gynecologic oncology.

Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO.

C. Haie-meder, M. Marcenaro, V. Vitale, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment for advanced cervical cancer: impact on quality of life.

S. Davidson, 2011, Critical reviews in oncology/hematology.

Hypoxia-Inducible Factor 1α Expression as an Intrinsic Marker of Hypoxia

A. Harris, S. Roberts, I. Stratford, 2004, Clinical Cancer Research.

Hypoxia-Inducible Factor 1α Expression as an Intrinsic Marker of Hypoxia

A. Harris, S. Roberts, I. Stratford, 2004, Clinical Cancer Research.

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix

I. Stratford, C. West, S. Davidson, 2005, British Journal of Cancer.

Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

R. Airley, I. Stratford, C. West, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy.

R. Swindell, S. Davidson, B. Carrington, 2003, Clinical radiology.

Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit

J. Tierney, P. Symonds, S. Davidson, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Assessment of factors influencing the outcome of radiotherapy for bladder cancer.

S. Davidson, R. Symonds, M. Snee, 1990, British journal of urology.

Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic.

G. Velikova, D. Sebag‐Montefiore, S. Davidson, 2015, Gynecologic oncology.

Late onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists

D. Peel, R. Swindell, H. Andreyev, 2011, Gut.

Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency.

B. Jeremic, A. Trotti, S. Davidson, 2007, International journal of radiation oncology, biology, physics.

Estimation of renal function -- what is appropriate in cancer patients?

J. Livsey, R. Swindell, S. Davidson, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.

J. Overgaard, C. West, M. Varia, 2001, International journal of radiation oncology, biology, physics.

A retrospective study of bladder morbidity in patients receiving intracavitary brachytherapy as all or part of their treatment for cervix cancer.

J. M. Wilkinson, M. Harris, R. Swindell, 2003, The British journal of radiology.

Late radiotherapy effects: is bowel morbidity adequately documented or patients' needs managed appropriately?

S. Faithfull, S. Davidson, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

The case for including bowel urgency in toxicity reporting after pelvic cancer treatment.

C. West, R. Swindell, S. Davidson, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Caseload and outcome after brachytherapy.

P. Symonds, S. Davidson, K. Drinkwater, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial

C. West, C. Dive, Susana Banerjee, 2015, The Lancet. Oncology.

The effects of pelvic radiotherapy on cancer survivors: symptom profile, psychological morbidity and quality of life.

M. Boulton, P. Rose, E. Watson, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Magnetic resonance imaging of primary vaginal carcinoma.

S. Davidson, B. Carrington, M. B. Taylor, 2007, Clinical radiology.

Apoptosis as predictor of response to radiotherapy in cervical carcinoma

S. Roberts, C. Potten, C. West, 1994, The Lancet.

Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.

S. Roberts, C. West, A. Sproston, 1995, British Journal of Cancer.

Comparison of two methods to assess tumour vasculature in human cervical carcinoma.

J. Moore, C. West, S. Davidson, 1991, International journal of radiation biology.

Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists

R. Swindell, A. Lalji, H. Andreyev, 2012, Supportive Care in Cancer.

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

W. Allum, J. Andreyev, H. Andreyev, 2011, Gut.

25th Paterson Symposium--is there a future for radiosensitivity testing?

C. West, D. Scott, S. Davidson, 1991, British Journal of Cancer.

Lack of a relationship between colony-forming efficiency and surviving fraction at 2 Gy.

R. James, C. West, S. Davidson, 1991, Radiation research.

Potential prognostic indicators for the radiotherapy of cervical carcinoma

S. Davidson, 1991 .

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

J. Logue, C. West, S. Davidson, 2000, British Journal of Cancer.

Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy.

N. Slevin, S. Davidson, Susan E Davidson, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy.

N. Slevin, S. Davidson, A. Sykes, 2009, European journal of cancer.

Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy.

A. Nahum, C. West, F. Buffa, 2001, International journal of radiation oncology, biology, physics.

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.

A. Harris, P. Ratcliffe, J. Pastorek, 2001, Cancer research.

Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.

S. A. Roberts, S. Roberts, C. West, 1993, British Journal of Cancer.

Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix

I. Stratford, C. West, C. Dive, 2005, British Journal of Cancer.

Radiation-induced micronuclei in human fibroblasts in relation to clonogenic radiosensitivity.

A. Kiltie, C. West, D. Scott, 1998, British Journal of Cancer.

A correlation between residual DNA double-strand breaks and clonogenic measurements of radiosensitivity in fibroblasts from preradiotherapy cervix cancer patients.

J. Hendry, A. Kiltie, S. Roberts, 1997, International journal of radiation oncology, biology, physics.

Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients

N. Slevin, R. Swindell, S. Davidson, 2013, The Journal of Laryngology & Otology.

The impact of radiotherapy late effects on quality of life in gynaecological cancer patients

R. Swindell, S. Davidson, J. Routledge, 2009, British Journal of Cancer.

GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding

A. Harris, R. Airley, I. Stratford, 2003, International journal of cancer.

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity

S. Roberts, J. Logue, C. West, 1999, British Journal of Cancer.

High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy.

S. Roberts, J. Logue, C. West, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical outcome for chemoradiotherapy in carcinoma of the cervix.

J. Livsey, R. Swindell, S. Davidson, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

LBA25_PRCIRCCA: A RANDOMISED DOUBLE BLIND PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL PLUS CEDIRANIB VERSUS CARBOPLATIN-PACLITAXEL PLUS PLACEBO IN METASTATIC/RECURRENT CERVICAL CANCER. (CRUK GRANT REF: C1256/A11416)

C. West, C. Dive, C. Gourley, 2014 .

Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer.

J. Livsey, R. Swindell, D. Farnell, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.

S. A. Roberts, S. Roberts, C. West, 1997, British Journal of Cancer.

Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.

Jens Overgaard, Christina Aquino-Parsons, Marianne Nordsmark, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

S. Burden, T. Lawrie, L. Wedlake, 2018, The Cochrane database of systematic reviews.

Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting.

G. Velikova, D. Sebag‐Montefiore, F. Efficace, 2015, International journal of radiation oncology, biology, physics.

Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy.

J. Logue, C. Taylor, T. Elliott, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

P. Lambin, P. Lambin, H. Thierens, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics

Joseph O Deasy, Alison M Dunning, Jenny Chang-Claude, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy.

J. Logue, C. West, J. Livsey, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short report: a morbidity scoring system for Clinical Oncology practice: questionnaires produced from the LENT SOMA scoring system.

R. Cowan, J. Logue, C. West, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix.

S. Roberts, C. West, R. Swindell, 2001, International journal of radiation oncology, biology, physics.

S05 03 SA – SURVIVING FRACTION AT 2 GY DETERMINATIONS FOR HUMAN TUMOURS - UPDATE OF THE MANCHESTER STUDY

C. West, S. Davidson, R. Hunter, 1991 .

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy

J. Logue, I. Stratford, C. West, 2000, British Journal of Cancer.

of the Cervix Measurements and Prognosis in Locally Advanced Carcinoma Intrinsic Marker of Hypoxia : Correlations with Tumor Oxygen Carbonic Anhydrase ( CA IX ) Expression , a Potential New Updated

A. Harris, P. Ratcliffe, J. Pastorek, 2001 .

Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus.

S. Davidson, A. Brewster, W. Makin, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumour stage, differentiation, patient age, host cell infiltration or patient survival

S. Davidson, R. Hunter, C. West, 1992, International journal of cancer.

Small cell carcinoma of the uterine cervix: a clinicopathological review.

J. Shanks, S. Davidson, A. Sykes, 1999, International journal of oncology.

Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy.

S. Burden, S. Lal, S. Davidson, 2013, The Cochrane database of systematic reviews.

Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.

J. Hendry, S. Roberts, C. Potten, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy

S. Burden, T. Lawrie, H. Andreyev, 2017 .

Quality of Life in Men Treated for Early Prostate Cancer: A Prospective Patient Preference Cohort Study

R. Cowan, N. Clarke, J. Logue, 2011 .

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix.

J P Logue, Asha D. Luthra, Andrew P Jones, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed.

J. Livsey, R. Swindell, S. Davidson, 2008, International journal of radiation oncology, biology, physics.

eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy

K. Franks, A. Henry, G. Velikova, 2018, Pilot and Feasibility Studies.

Usability testing of an online symptom report and management system in radical prostate radiotherapy (RT) patients: preliminary findings of the eRAPID RT programme

A. Henry, G. Velikova, M. Holmes, 2016 .

OC-0416: eRAPID: Electronic self-report and management of adverse-events for radical prostate radiotherapy (RT) patients

K. Franks, A. Henry, G. Velikova, 2015 .

The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.

V. Gebski, J. Overgaard, C. West, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults.

S. Davidson, C. Higham, C. Henson, 2013, The Cochrane database of systematic reviews.

Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma.

V. Khoo, C. West, R. Swindell, 2003, International journal of radiation oncology, biology, physics.

Endometrial adenocarcinoma: an analysis of treatment and outcome.

J. Livsey, R. Swindell, Daniel Webber‐Rookes, 2008, Oncology reports.

The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer.

H. Yosef, N. Reed, J. Paul, 2000, European journal of cancer.

Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix

D L Buckley, D. Buckley, Andrew P Jones, 2009, British Journal of Cancer.

Dynamics of circulating vascular endothelial growth factor‐A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients

G. Jayson, C. West, C. Dive, 2019, British journal of clinical pharmacology.

Poor prognosis associated with human papillomavirus α7 genotypes in cervical carcinoma cannot be explained by intrinsic radiosensitivity.

Crispin J. Miller, S. de Sanjosé, P. Stern, 2013, International journal of radiation oncology, biology, physics.

Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors.

Geoff J M Parker, Alan Jackson, Caleb Roberts, 2009, International journal of radiation oncology, biology, physics.

Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy

S. Burden, J. Mclaughlin, M. Eden, 2020, BMJ open gastroenterology.

The in vitro radiosensitivity of human head and neck cancers.

R. James, C. West, N. Slevin, 1998, British Journal of Cancer.

Late radiation morbidity in a patient with carcinoma of the cervix.

C. West, S. Davidson, W. Appel, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.

K. Franks, A. Henry, G. Velikova, 2017, International journal of radiation oncology, biology, physics.

Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?

J. Hendry, C. West, S. Davidson, 2009, Brachytherapy.

A comparison of 4 methods for assessing tumor vascularity in carcinoma of the cervix.

J. Moore, S. Davidson, C. West, 1994, International journal of oncology.

Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancer.

R. Cowan, J. Logue, J. Livsey, 2010, European journal of cancer.

A comparison of tracer kinetic models for T1‐weighted dynamic contrast‐enhanced MRI: Application in carcinoma of the cervix

S. Sourbron, D. Buckley, Andrew P Jones, 2010, Magnetic resonance in medicine.

Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.

A. Harris, S. Roberts, I. Stratford, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.

K. Franks, A. Henry, G. Velikova, 2017, International journal of radiation oncology, biology, physics.

Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach

J. Blazeby, G. Velikova, D. Sebag‐Montefiore, 2015, The Lancet.

Measurement tools for gastrointestinal symptoms in radiation oncology

C. West, S. Davidson, 2009, Current opinion in supportive and palliative care.

Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research

A. Coulter, T. Wykes, R. Fitzpatrick, 2016, Health and Quality of Life Outcomes.